Suheung Co., Ltd. (008490.KS)
KRW 12880.0
(-1.68%)
KRW 12880.0
(-1.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 993.73 Billion KRW | 7.27% |
| 2022 | 926.41 Billion KRW | 14.38% |
| 2021 | 809.95 Billion KRW | 5.74% |
| 2020 | 765.98 Billion KRW | 8.06% |
| 2019 | 708.86 Billion KRW | 10.92% |
| 2018 | 639.1 Billion KRW | 7.36% |
| 2017 | 595.28 Billion KRW | 1.6% |
| 2016 | 585.89 Billion KRW | 5.23% |
| 2015 | 556.75 Billion KRW | 13.34% |
| 2014 | 491.2 Billion KRW | 5.29% |
| 2013 | 466.54 Billion KRW | 0.02% |
| 2012 | 466.46 Billion KRW | 7.42% |
| 2011 | 434.22 Billion KRW | 20.7% |
| 2010 | 359.75 Billion KRW | 40.95% |
| 2009 | 255.24 Billion KRW | -0.57% |
| 2008 | 256.71 Billion KRW | 33.53% |
| 2007 | 192.25 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1013.1 Billion KRW | 1.95% |
| 2024 Q2 | 1028.49 Billion KRW | 1.52% |
| 2023 FY | 993.73 Billion KRW | 7.27% |
| 2023 Q4 | 993.73 Billion KRW | -2.6% |
| 2023 Q1 | 968.88 Billion KRW | 4.58% |
| 2023 Q3 | 1020.31 Billion KRW | 2.11% |
| 2023 Q2 | 999.21 Billion KRW | 3.13% |
| 2022 Q1 | 880.32 Billion KRW | 8.69% |
| 2022 FY | 926.41 Billion KRW | 14.38% |
| 2022 Q4 | 926.41 Billion KRW | -3.54% |
| 2022 Q3 | 960.38 Billion KRW | 5.62% |
| 2022 Q2 | 909.26 Billion KRW | 3.29% |
| 2021 FY | 809.95 Billion KRW | 5.74% |
| 2021 Q1 | 804.7 Billion KRW | 5.05% |
| 2021 Q3 | 839.99 Billion KRW | 4.33% |
| 2021 Q4 | 809.95 Billion KRW | -3.58% |
| 2021 Q2 | 805.15 Billion KRW | 0.06% |
| 2020 Q3 | 783.7 Billion KRW | 2.24% |
| 2020 Q2 | 766.51 Billion KRW | 4.85% |
| 2020 Q1 | 731.06 Billion KRW | 3.13% |
| 2020 FY | 765.98 Billion KRW | 8.06% |
| 2020 Q4 | 765.98 Billion KRW | -2.26% |
| 2019 Q4 | 708.86 Billion KRW | -0.55% |
| 2019 FY | 708.86 Billion KRW | 10.92% |
| 2019 Q3 | 712.75 Billion KRW | -0.52% |
| 2019 Q2 | 716.47 Billion KRW | 7.78% |
| 2019 Q1 | 664.75 Billion KRW | 4.01% |
| 2018 FY | 639.1 Billion KRW | 7.36% |
| 2018 Q1 | 604.26 Billion KRW | 1.51% |
| 2018 Q2 | 627.39 Billion KRW | 3.83% |
| 2018 Q3 | 641.79 Billion KRW | 2.3% |
| 2018 Q4 | 639.1 Billion KRW | -0.42% |
| 2017 Q1 | 577.38 Billion KRW | -1.45% |
| 2017 FY | 595.28 Billion KRW | 1.6% |
| 2017 Q4 | 595.28 Billion KRW | -2.29% |
| 2017 Q3 | 609.23 Billion KRW | 4.07% |
| 2017 Q2 | 585.43 Billion KRW | 1.39% |
| 2016 FY | 585.89 Billion KRW | 5.23% |
| 2016 Q4 | 585.89 Billion KRW | 5.59% |
| 2016 Q2 | 566.95 Billion KRW | 2.68% |
| 2016 Q3 | 554.89 Billion KRW | -2.13% |
| 2016 Q1 | 552.16 Billion KRW | -0.83% |
| 2015 Q3 | 550.94 Billion KRW | 2.86% |
| 2015 Q4 | 556.75 Billion KRW | 1.05% |
| 2015 FY | 556.75 Billion KRW | 13.34% |
| 2015 Q2 | 535.63 Billion KRW | 7.61% |
| 2015 Q1 | 497.73 Billion KRW | 1.33% |
| 2014 Q2 | 479.23 Billion KRW | -0.03% |
| 2014 Q1 | 479.35 Billion KRW | 2.75% |
| 2014 Q3 | 489.88 Billion KRW | 2.22% |
| 2014 FY | 491.2 Billion KRW | 5.29% |
| 2014 Q4 | 491.2 Billion KRW | 0.27% |
| 2013 FY | 466.54 Billion KRW | 0.02% |
| 2013 Q4 | 466.54 Billion KRW | 0.45% |
| 2013 Q3 | 464.45 Billion KRW | -7.55% |
| 2013 Q2 | 502.36 Billion KRW | 3.45% |
| 2013 Q1 | 485.59 Billion KRW | 4.1% |
| 2012 Q1 | 378.94 Billion KRW | 0.0% |
| 2012 Q4 | 466.46 Billion KRW | 0.0% |
| 2012 FY | 466.46 Billion KRW | 7.42% |
| 2011 FY | 434.22 Billion KRW | 20.7% |
| 2011 Q3 | 328.21 Billion KRW | 4.36% |
| 2011 Q2 | 314.5 Billion KRW | 13.77% |
| 2011 Q1 | 276.45 Billion KRW | 0.0% |
| 2010 Q1 | 233.31 Billion KRW | 0.0% |
| 2010 Q3 | 252.37 Billion KRW | -2.54% |
| 2010 FY | 359.75 Billion KRW | 40.95% |
| 2010 Q2 | 258.94 Billion KRW | 10.99% |
| 2009 FY | 255.24 Billion KRW | -0.57% |
| 2009 Q3 | 179.19 Billion KRW | 5.1% |
| 2009 Q2 | 170.5 Billion KRW | 1.23% |
| 2009 Q1 | 168.44 Billion KRW | 0.0% |
| 2008 Q1 | 162.53 Billion KRW | 0.0% |
| 2008 FY | 256.71 Billion KRW | 33.53% |
| 2008 Q2 | 152.02 Billion KRW | -6.46% |
| 2008 Q3 | 154.55 Billion KRW | 1.66% |
| 2007 Q3 | 151.65 Billion KRW | 7.25% |
| 2007 Q1 | 135.21 Billion KRW | 0.0% |
| 2007 FY | 192.25 Billion KRW | 0.0% |
| 2007 Q2 | 141.4 Billion KRW | 4.58% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -401.347% |
| Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | 49.224% |
| Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -13.311% |
| HANDOK Inc. | 790.33 Billion KRW | -25.735% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -482.427% |
| Yuhan Corporation | 2814.07 Billion KRW | 64.687% |
| Dong-A ST Co., Ltd. | 1315.21 Billion KRW | 24.443% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -963.059% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | 49.092% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -314.494% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -111.928% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -764.32% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -320.098% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -185.24% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -401.347% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -137.061% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -98.837% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -68.602% |
| JW Holdings Corporation | 1176.26 Billion KRW | 15.518% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -62.572% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | 29.142% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -54.058% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -183.857% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -545.112% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -168.085% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -103.916% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -401.347% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | 7.822% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | 43.867% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -54.058% |
| Yuhan Corporation | 2814.07 Billion KRW | 64.687% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | -12.925% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -338.541% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -54.058% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -136.66% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -111.947% |
| CKD Bio Corp. | 293.78 Billion KRW | -238.253% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -95.618% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -75.891% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -147.675% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -183.857% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | 31.749% |
| Boryung Corporation | 922.36 Billion KRW | -7.738% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -124.593% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -111.928% |
| JW Lifescience Corporation | 255.83 Billion KRW | -288.427% |